TTI-0102, a Cysteamine Precursor for Mild to Moderate TBI: Dosing and Feasibility Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04262895

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:26.236172+00:00

Published At

2021-10-26T00:00:00+00:00

Record Updated At

2021-10-26

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Mild to Moderate TBI", "Posttraumatic Stress Disorder"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-10-26"

protocolSection.identificationModule.nctId

"NCT04262895"

protocolSection.identificationModule.officialTitle

"TTI-0102, a Cysteamine Precursor for Mild to Moderate TBI: Dosing and Feasibility Study"

protocolSection.statusModule.overallStatus

"WITHDRAWN"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Mild to Moderate TBI (protocolSection.conditionsModule.conditions)
• Posttraumatic Stress Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.